T34M (p.Thr34Met) variant of SOST (Sclerostin)

T34M (p.Thr34Met) in SOST (Sclerostin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.80 / 1. The record also includes population frequency data and structural context.

T34M (p.Thr34Met) variant details